Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report

Pediatrics

Volumn 129, Issue 5, 2012, Pages

  Buchanan, Ashley L ^a   Montepiedra, Grace ^a   Sirois, Patricia A ^b   Kammerer, Betsy ^c   Garvie, Patricia A ^d   Storm, Deborah S ^e   Nichols, Sharon L ^f  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e The State University of New Jersey   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Adolescents; Children; HIV; Pediatric

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CAREGIVER; CHILD; CHILD BEHAVIOR; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT;

EID: 84860591105     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1740     Document Type: Article

References (19)

1. Patel K, Hernán MA, Williams PL, et al; Pediatric AIDS Clinical Trials Group 219/219C Study Team. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis. 2008;46(4):507-515 (Pubitemid 351263487)
2. Ballif M, Ledergerber B, Battegay M, et al Swiss HIV Cohort Study. Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS ONE. 2009;4(12):e8275
3. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283(3):381-390 (Pubitemid 30051757)
4. Brogly S, Williams P, Seage GR III, Oleske JM, Van Dyke R, McIntosh K PACTG 219C Team. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. JAMA. 2005;293(18):2213-2220 (Pubitemid 40629187)
5. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157(3):249-255 (Pubitemid 36343379)
6. Van Dyke R, Lee S, Johnson G, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4). Available at: www.pediatrics.org/cgi/content/full/109/4/e61
7. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124-133
8. Farley JJ, Montepiedra G, Storm D, et al; PACTG P1042S Team. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count. J Dev Behav Pediatr. 2008;29(5):377-384
9. Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28(5):355-361 (Pubitemid 36750459)
10. Martin S, Elliott-DeSorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J. 2007;26(1):61-67 (Pubitemid 46045754)
11. Mellins CA, Brackis-Cott E, Richards A, Abrams E, Nicholas S. Patterns of HIV status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatry. 2003;7:101-114 (Pubitemid 34081353)
12. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035-1041 (Pubitemid 40824294)
13. Naar-King S, Montepiedra G, Nichols S, et al; PACTG 1042S Team. Allocation of family responsibility for illness management in pediatric HIV. J Pediatr Psychol. 2009;34(2):187-194
14. Williams PL, Storm D, Montepiedra G, et al; PACTG 219C Team. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118(6). Available at: www.pediatrics.org/cgi/ content/full/118/6/e1745
15. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep. 1994;43(RR-12):1-10
16. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19
17. Anderson BJ, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Ped Psych. 1990;15:477-492 (Pubitemid 20366295)
18. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438
19. Havens J, Mellins C, Hunter J. Psychiatric aspects of HIV/AIDS in childhood and adolescence. In: Rutter M, Taylor E, eds. Child and Adolescent Psychiatry. 4th ed. Oxford, UK: Blackwell; 2002:828-841